Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit

Abstract

Drug delivery systems are required to be safe, minimally invasive and effectively delivery drug to the target tissues. But delivery drugs to the eye has not yet satisfied this need. Here, we focused on examining the distribution of dexamethasone (DEX) in ocular and plasmic samples following controllable continuous sub-Tenon drug delivery (CCSDD) of dexamethasone disodium phosphate (DEXP) in rabbit, and to compare that with two traditional routes: subconjunctival injection and intravenous injection. The DEX concentration was analyzed by Shimadzu LC-MS 2010 system. In CCSDD group, during observed 24 h, the mean DEX level in collected samples from highest to lowest following in order: sclera, cornea, retina/choroid, iris, plasma, aqueous humor, lens and vitreous body. In ocular solid tissue, the DEX level in posterior segment is higher than in anatomic corresponding anterior segment, but it is opposite in ocular fluid tissue. High levels of DEX were maintained at 12 h in the ocular tissue immediately after the administration. Even at 24 h, the mean DEX concentration was 31.72 ng/ml and 22.40 ng/ml in aqueous and vitreous, respectively. In CCSDD group, the ocular DEX exposure (AUC) is much higher and plasma exposure is much less than IV group, and it is also similar in SC group except iris. The amount of DEX levels are markedly increased in ocular tissues but it yield lower plasma levels indicating reduction of systemic absorption by CCSDD. Thus, CCSDD is an effective method of delivering DEX into anterior and posterior segment of the eye.

Improved Treatment on Ocular Inflammation with Rationally Designed Thermoresponsive Nanocomposite Formulation

“…[5] It was reported that subconjunctival injection of hydrophobic drugs could provide the highest drug concentration in sclera, then in retina/choroid and cornea, followed by in iris, plasma, aqueous, lens, and vitreous in order. [24] And subconjunctival administration could present a higher drug concentration in eye tissues, while only obtain a lower drug concentration in the systemic circulation through the conjunctival blood and lymphatic vessels. The systemic drug distribution after a subconjunctival administration is negligible.…”

PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19

“…Dexamethasone also cause diabetes related complications, immune suppressor and cause hypertension. Poor gastrointestinal stability, low bioavailability, poor transport behavior and side effect on other organs like kidney limit its therapeutic effectivity ( Alessi et al, 2020 ; Huang et al, 2017 ).…”